期刊文献+

常见药物转运体基因多态性对药动学影响及研究进展 被引量:5

Effects of common drug-transporters genetic polymorphisms on pharmacokinetics
原文传递
导出
摘要 药物转运体在体内药物的吸收(absorption)、分布(distribution)、代谢(metabolism)及排泄(excretion)的过程(ADME)中发挥着关键的作用。转运体在各组织器官的不同分布以及其基因多态性,导致某些药物的吸收、分布、代谢和排泄过程产生明显的个体差异。随着药物基因组学的快速发展,关于转运体基因多态性的研究报道越来越多。本文对近年来人体主要药物转运体基因多态性在药动学和药效学中的影响研究进行综述。 Drug transporters play a key role in absorption,distribution,metabolism and excretion process(ADME process)of drugs.Different distribution of transporters in tissues and organs as well as its genetic polymorphisms can result in individual differences of absorption,distribution,metabolism and excretion of drugs significantly.With rapid development of pharmacogenomics,researches of transporters' genetic polymorphisms have been more and more reported.In this paper,we will summarize influences of transporters' genetic polymorphisms on pharmacokinetics and pharmacodynamics in recent few years.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2016年第13期1144-1148,1150,共6页 Chinese Journal of Hospital Pharmacy
关键词 转运体 基因多态性 药动学 transporters genetic polymorphisms pharmacokinetics
  • 相关文献

参考文献43

  • 1Fromm MF, Kim RB. Drug transporters [ M ]. Erlangen :Springer Verlag Berlin Heidelberg,2011: 5-6.
  • 2Juliano RL, Ling V. A surface glycoprotein modulating drugpermeability in Chinese hamster ovary cell mutants [J]. Bio-chim Biophys Acta,1976,455 (1) : 152-162.
  • 3Hagenbuch B,Gui C. Xenobiotic transporters of the human or-ganic anion transporting polypeptides (OATP) family [J]. Xe-nobiotica,2008,38(7/8): 778-801.
  • 4Maeda K. Organic anion transporting polypeptide (OATP)lBland OATP1B3 as important regulators of the pharmacokineticsof substrate drugs[J]. Biol Pharm Bull,2015,38(2) : 155-168.
  • 5Tirona RG, Leake BF, Merino G,et al. Polymorphisms inOATP-C: identification of multiple allelic variants associatedwith altered transport activity among European- and African-Americans[J]. J Biol Chem,2001,276(38) : 35669-35675.
  • 6Nishizato Y,Ieiri I,Suzuki W^et al. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22 A8) genes : Consequencesfor pravastatin pharmacokinetics [J]. Clin Pharmacol Ther,2003,73(6): 554-565.
  • 7Tornio A, Vakkilainen J, Neuvonen M,et al, SLCOlBl poly-morphism markedly affects the pharmacokinetics of lovastatinacid[J]. Pharmacogenet Genomics,2015,25(8) : 382-387.
  • 8袁钊,李新华,黄世博,夏春华,熊玉卿.OATP1B1及CYP3A4基因多态性对阿托伐他汀转运代谢影响的分子机制[J].中国医院药学杂志,2013,33(13):1035-1041. 被引量:10
  • 9Kalliokoski A, Neuvonen PJ, Niemi M. SLCOlBl polymor-phism and oral antidiabetic drugs [J]. Basic Clin PharmacolToxicol,2010,107(4): 775-781.
  • 10Iida A,Saito S,Sekine A,etal. Catalog of 258 single-nucleotidepolymorphisms (SNPs) in genes encoding three organic aniontransporters? three organic anion-transporting polypeptides,and three NADH : ubiquinone oxidoreductase flavoproteins[J 3.J Hum Genet,2001,46(11) : 668-683.

二级参考文献36

  • 1张莉莉,吕安林,贾国良,王海昌.载脂蛋白E基因多态性对他汀类药物调脂消斑的影响[J].第四军医大学学报,2004,25(11):1029-1031. 被引量:10
  • 2宋仁兴,张振兴,王永和.MDR1基因SNPs与难治性癫痫的相关性研究进展[J].国际神经病学神经外科学杂志,2006,33(6):589-592. 被引量:1
  • 3Hoffmeyer S, Burk O, von Richter O, et al. Functional poly morphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glyco protein expression and activity in vivo [J]. Proc Natl Acad Sci USA, 2000,97 (7) : 3473-3478.
  • 4Loscher W, Potschka H. Role of multidrug transporters in pharmaeoresistance to antiepileptic drugs[J]. J Pharmacol Exp Ther, 2002,301 ( 1 ) : 7-14.
  • 5Ueda K, Cardarelli C, Gottesman MM, et al. Expression of a full-length cDNA for the human "MDR1" gene confers resist- ance to colchicine, doxorubicin, and vinblastine[J]. Proc Natl Acad Sci USA, 1987,84 (9) : 3004-3008.
  • 6Kim RB, Leake BF, Choo EF,et al. Identification of functional- ly variant MDR1 alleles among European Americans and Afri- can Americans [J ]. Clin Pharmacol Ther, 200l, 70 ( 2 ) : 189- 199.
  • 7Fellay J, Marzolini C, Meaden ER,et al. Response to antiretro- viral treatment in HIV-l-infected individuals with allelic vari- ants of the multidrug resistance transporter 1 : a pharmacoge- netics study[J]. Lancet, 2002,359 (9300) : 30- 36.
  • 8Wasilewska A, Zalewski G, Chyczewski L, et al. MDR-1 gene polymorphisms and clinical course of steroid-responsive ne- phrotic syndrome in children[J]. Pediatr Nephrol, 2007,22 (1) : 44-51.
  • 9Bosch TM, Huitema AD, Doodeman VD, et al. Pharmacogenet ic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel [J]. Clin Cancer Res, 2006, 12 (19) : 5786-5793.
  • 10Tanabe M,Ieiri I, Nagata N, et al. Expression of P-glycopro- tein in human placenta., relation to genetic polymorphism of the multidrug resistance (MDR) I gene[J]. J Pharmaeol Exp Ther, 2001,297(3): 1137-1143.

共引文献14

同被引文献33

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部